Although several studies have shown that PSMA is expressed in the vasculature of bladder cancer (33–35), these studies only examined limited samples, or did not analyze the association between vascular PSMA expression and clinicopathological features and prognosis systematically. The gene discussed is FOLH1; the disease is urinary bladder cancer.